{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "dysplasia",
      "head and neck cancer",
      "laryngeal neoplasms",
      "mTORC",
      "mammalian target of rapamycin complex",
      "metformin",
      "oral cavity cancer"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28103701",
  "DateCompleted": {
    "Year": "2017",
    "Month": "04",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "02",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "01",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1177/0003489416688478"
    ],
    "Journal": {
      "ISSN": "1943-572X",
      "JournalIssue": {
        "Volume": "126",
        "Issue": "4",
        "PubDate": {
          "Year": "2017",
          "Month": "Apr"
        }
      },
      "Title": "The Annals of otology, rhinology, and laryngology",
      "ISOAbbreviation": "Ann Otol Rhinol Laryngol"
    },
    "ArticleTitle": "Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients.",
    "Pagination": {
      "StartPage": "340",
      "EndPage": "343",
      "MedlinePgn": "340-343"
    },
    "Abstract": {
      "AbstractText": [
        "Metformin is an oral anti-hyperglycemic agent used to treat type 2 diabetes mellitus (DM). In vitro and animal models have shown that metformin can prevent the progression of oral lesions to carcinoma; however, there is conflicting data in the clinical literature regarding risk reduction for malignancy in head and neck cancer (HNC).",
        "Case series.",
        "We present 3 cases in which adjuvant metformin therapy was used to treat recurrent and multifocal dysplastic lesions in previously treated nondiabetic HNC patients.",
        "Patients included 1 with a history of oral cavity squamous cell carcinoma (SCC) and 2 with a history of laryngeal SCC. Follow-up time ranged between 3 and 33 months. All 3 patients showed complete or partial regression of the remaining mucosal lesions and did not require any additional surgeries.",
        "We present 3 cases of nondiabetic HNC patients with field cancerization who showed a good response to adjuvant therapy with metformin. The nondiabetic population is not affected by confounding factors such as increased risk of malignancy and decreased overall survival that is itself associated with abnormal glucose metabolism and is therefore an excellent cohort in which to study the use of adjuvant metformin therapy in HNC patients."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "1 Department of Otolaryngology-Head and Neck Surgery, Montefiore Medical Center, Bronx, New York, USA."
          }
        ],
        "LastName": "Lerner",
        "ForeName": "Michael Zvi",
        "Initials": "MZ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "2 Maimonides Medical Center, Voice and Swallowing Disorders, Division of Otolaryngology-Head and Neck Surgery, Brooklyn, New York, USA."
          }
        ],
        "LastName": "Mor",
        "ForeName": "Niv",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "3 Yale New Haven Health System, New Haven, Connecticut, USA."
          }
        ],
        "LastName": "Paek",
        "ForeName": "Hyung",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "4 New York Center for Voice and Swallowing Disorders, New York, New York, USA."
          }
        ],
        "LastName": "Blitzer",
        "ForeName": "Andrew",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "4 New York Center for Voice and Swallowing Disorders, New York, New York, USA."
          }
        ],
        "LastName": "Strome",
        "ForeName": "Marshall",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Ann Otol Rhinol Laryngol",
    "NlmUniqueID": "0407300",
    "ISSNLinking": "0003-4894"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Hypoglycemic Agents"
    },
    {
      "RegistryNumber": "9100L32L2N",
      "NameOfSubstance": "Metformin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Carcinoma, Squamous Cell"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Glottis"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Head and Neck Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Hypoglycemic Agents"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Laryngeal Neoplasms"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Leukoplakia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Metformin"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Mouth Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mucous Membrane"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Neoplasm Recurrence, Local"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Squamous Cell Carcinoma of Head and Neck"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Tongue Neoplasms"
    }
  ]
}